MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rybalchenko, V.
Right arrow Articles by Skryma, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rybalchenko, V.
Right arrow Articles by Skryma, R.

Vol. 59, Issue 6, 1376-1387, June 2001

Verapamil Inhibits Proliferation of LNCaP Human Prostate Cancer Cells Influencing K+ Channel Gating

Volodymr Rybalchenko, Natalia Prevarskaya, Fabien Van Coppenolle, Guillaume Legrand, Loic Lemonnier, Xuefen Le Bourhis, and Roman Skryma

Laboratoire de Physiologie Cellulaire, Institut National de la Santé et de la Recherche Médicale EPI-9938, USTL, Villeneuve d'Ascq, France

The mechanisms of verapamil and tetraethylammonium (TEA) inhibition of voltage-gated K+ channels in LNCaP human prostate cancer cells were studied in whole-cell and outside/inside-out patch-clamp configurations. Rapidly activating outward K+ currents (IK) exhibited neither C-type, nor rapid (human ether á go-go-related gene-type) inactivation. With 2 mM [Mg2+]o, IK activation kinetics was independent of holding potential, suggesting the absence of ether á go-go-type K+ channels. Extracellular applications of TEA and verapamil (IC50 = 11 µM) rapidly (12 s) inhibited IK in LNCaP cells. Blocking was also rapidly reversible. Intracellular TEA (1 mM), verapamil (1 mM), and membrane-impermeable N-methyl-verapamil (25 µM) did not influence whole-cell IK, although both phenylalkylamines inhibited single-channel currents in inside-out patches. Extracellular application of N-methyl-verapamil (25 µM) had no influence on IK. Our results are compatible with the hypothesis that, in LNCaP cells expressing C-type inactivation-deficient voltage-activated K+ channels, phenylalkylamines interact with an intracellular binding site, and probably an additional hydrophobic binding site that does not bind charged phenylalkylamines. The inhibiting effects of verapamil and TEA on IK were additive, suggesting independent K+-channel blocking mechanisms. Indeed, TEA (1 mM) reduced a single-channel conductance (from 7.3 ± 0.5 to 3.2 ± 0.4 pA at a membrane potential of +50 mV, n = 6), whereas verapamil (10 µM) reduced an open-channel probability (from 0.45 ± 0.1 in control to 0.1 ± 0.09 in verapamil-treated cells, n = 9). The inhibiting effects of verapamil and TEA on LNCaP cell proliferation were not multiplicative, suggesting that both share a common antiproliferative mechanism initiated through a K+ channel block.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Renaudo, V. Watry, A.-A. Chassot, G. Ponzio, J. Ehrenfeld, and O. Soriani
Inhibition of Tumor Cell Proliferation by {sigma} Ligands Is Associated with K+ Channel Inhibition and p27kip1 Accumulation
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1105 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-B. Huang, A. L. Kindzelskii, A. J. Clark, and H. R. Petty
Identification of Channels Promoting Calcium Spikes and Waves in HT1080 Tumor Cells: Their Apparent Roles in Cell Motility and Invasion
Cancer Res., April 1, 2004; 64(7): 2482 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. D. Debes, R. O. Roberts, D. J. Jacobson, C. J. Girman, M. M. Lieber, D. J. Tindall, and S. J. Jacobsen
Inverse Association between Prostate Cancer and the Use of Calcium Channel Blockers
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 255 - 259.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
V. V. Artym and H. R. Petty
Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and {beta}1-Integrins on the Plasma Membrane of Melanoma Cells: Effects of Cell Adherence and Channel Blockers
J. Gen. Physiol., June 10, 2002; 120(1): 29 - 38.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics